Mechanisms underlying mast cell influence on EAE disease course

Molecular Immunology

Volumn 38, Issue 16-18, 2002, Pages 1373-1378

  Brown, Melissa A ^a,b   Tanzola, Melinda B ^b   Robbie Ryan, Michaela ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Graduate Program In Immunology and Molecular Pathogenesis   (United States)

Author keywords

Autoimmunity; CNS; EAE disease; Fc receptors; Mast cell deficient mice; Mast cells; Multiple sclerosis

Indexed keywords

ANTIBODY; FC RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; CELL ACTIVATION; CELL FUNCTION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CROSS LINKING; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; INFLAMMATION; MAST CELL; MOUSE STRAIN; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; CYTOLOGY; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; MOUSE; PHYSIOLOGY; REVIEW;

RODENTIA;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HEMATOPOIETIC STEM CELLS; MAST CELLS; MICE; MULTIPLE SCLEROSIS;

EID: 0036034838     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00091-3     Document Type: Conference Paper

References (32)

1. Ansel J.C., Brown J.R., Payan D.G., Brown M.A. Substance P selectively activates TNF-α gene expression in murine mast cells. J. Immunol. 150:1993;4478-4485.
2. Bebo B.F. Jr., Yong T., Orr E.L., Linthicum D.S. Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;340-348.
3. Bernard, C.C.A., Mandel, T., Mackay, I.R., 1992. Experimental models of human autoimmune disease: overview and prototypes. In: Rose, N.R., Mackay, I.R. (Eds.), The Autoimmune Diseases II. Academic Press, San Diego, pp. 47-106.
4. Bernard C.C.A., Johns T.G., Slavin A., Ichikawa M., Ewing C., Liu J., Bettadapura J. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:1997;77-88.
5. Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122:1994;210-213.
6. Brosnan C.F., Tansey F.A. Delayed onset of experimental allergic neuritis in rats treated with reserpine. J. Neuropath. Exp. Neurol. 43:1984;84-93.
7. Cross A.H., Trotter J.L., Lyons J. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112:2001;1-14.
8. Dietsch G.N., Hinrichs D.J. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142:1989;1476-1481.
9. Dietsch G.N., Hinrichs D.J. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell. Immunol. 135:1991;541-548.
10. Dines K.C., Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropath. Exp. Neurol. 56:1997;627-640.
11. Friend D.S., Gurish M.F., Austen K.F., Hunt J., Stevens R.L. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J. Immunol. 165:2000;344-352.
12. Galli S., Wershil B. The two faces of the mast cell. Nature. 381:1996;21-22.
13. Galli S.J., Tsai M., Gordon J.R., Geissler E.N., Wershil B.K. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci. Ann. N.Y. Acad. Sci. 664:1992;69-88.
14. Ibrahim M.Z.M., Reder A.T., Lawand R., Takash W., Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:1996;131-138.
15. Johnson D., Krenger W. Interactions of mast cells with the nervous system - recent advances. Neurochem. Res. 17:1992;939-951.
16. Johnson D., Seeldrayers P.A., Weiner H.L. The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 44:1988a;195-198.
17. Johnson D., Weiner H.L., Seeldrayers P.A. Role of mast cells in peripheral nervous system demyelination. Ann. N.Y. Acad. Sci. 540:1988;727-731.
18. Lin T.J., Issekutz T.B., Marshall J.S. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J. Immunol. 165:2000;211-220.
19. Malaviya R.E., Ross E., Jakschik B.A., Abraham S.N. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J. Clin. Invest. 93:1994;1645-1653.
20. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 26:1995;1951-1959.
21. v mice. J. Exp. Med. 162:1985;1025-1043.
22. Neuman J. Ueber das Vorkommen der sogneannten "Mastzellen" bei pathologischen Veraenderungen des Gehirns. Arch. Pathol. Anat. Physiol. Virchows. 122:1890;378-381.
23. Nygen H., Dahlen G. Complement-dependent histamine release from rat peritoneal mast cells, induced by liposaccharides from Bacteroides oralis, Fusobacterium nucleatum and Veillonella parvula. J. Oral Pathol. 10:1981;87-94.
24. Orr E.L. Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis. Ann. N.Y. Acad. Sci. 540:1988;723-726.
25. Rodewald H.-R., Dessing M., Dvorak A.M., Galli S.J. Identification of a committed precursor for the mast cell lineage. Science. 271:1996;819-822.
26. Rozniecki J.J., Hauser S.L., Strein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37:1995;63-66.
27. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191:2000;813-822.
28. Seeldrayers P.A., Yasui D., Weiner H.L., Johnson D. Treatment of experimental allergic neuritis with nedocromil sodium, an anti-inflammatory drug with mast cell stabilizing properties. J. Neuroimmunol. 25:1989;221-226.
29. Silver R., Silverman A.J., Vitkovic L., Lederhendler I.I. Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19:1996;25-31.
30. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
31. Wang H.-W., Tedia N., Lloyd A.R., Wakefield D., McNeil H.P. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102:1998;1617-1626.
32. Zhuang X., Silverman A.-J., Silver R. Mast cell number and maturation in the central nervous system: influence of tissue type, location and exposure to hormones. Neuroscience. 80:1997;1237-1245.